tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks 50 IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFs
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA

IPHYF Stock Latest News

Innate Pharma Presents Promising Preclinical Data for IPH6501 at EHA Congress
Company AnnouncementsInnate Pharma Presents Promising Preclinical Data for IPH6501 at EHA Congress
3d ago
6K
Innate Pharma presents preclinical data for IPH6501 at EHA
PremiumThe Fly
Innate Pharma presents preclinical data for IPH6501 at EHA
3d ago
IPHA
Innate Pharma to Participate in Major Healthcare Conferences in June 2025
PremiumCompany Announcements
Innate Pharma to Participate in Major Healthcare Conferences in June 2025
20d ago
6K
Innate Pharma Adopts New Governance Structure Following AGM
PremiumCompany Announcements
Innate Pharma Adopts New Governance Structure Following AGM
24d ago
6K
Innate Pharma Presents Promising Lacutamab Data at ASCO 2025
PremiumCompany Announcements
Innate Pharma Presents Promising Lacutamab Data at ASCO 2025
24d ago
6K
Innate Pharma presents long-term follow-up data from TELLOMAK trial
PremiumThe FlyInnate Pharma presents long-term follow-up data from TELLOMAK trial
24d ago
IPHA
Innate Pharma’s Abstracts Selected for ASCO 2025 Annual Meeting
Premium
Company Announcements
Innate Pharma’s Abstracts Selected for ASCO 2025 Annual Meeting
28d ago
6K
Innate Pharma’s ANKET® Abstract Selected for EHA 2025 Congress
Premium
Company Announcements
Innate Pharma’s ANKET® Abstract Selected for EHA 2025 Congress
1M ago
6K
Innate Pharma Secures €15 Million Sanofi Investment and Advances Key Therapies
PremiumCompany Announcements
Innate Pharma Secures €15 Million Sanofi Investment and Advances Key Therapies
1M ago
6K
Innate Pharma Announces Share and Voting Rights Update as of May 5, 2025
PremiumCompany Announcements
Innate Pharma Announces Share and Voting Rights Update as of May 5, 2025
1M ago
6K
Innate Pharma Schedules Q1 2025 Business Update Conference Call
PremiumCompany Announcements
Innate Pharma Schedules Q1 2025 Business Update Conference Call
1M ago
6K
Innate Pharma Files 2024 Annual Reports with AMF and SEC
PremiumCompany Announcements
Innate Pharma Files 2024 Annual Reports with AMF and SEC
2M ago
6K
Innate Pharma Unveils Promising Preclinical Data for IPH4502 at AACR 2025
PremiumCompany AnnouncementsInnate Pharma Unveils Promising Preclinical Data for IPH4502 at AACR 2025
2M ago
6K
Innate Pharma Files 2024 Annual Report and Registration Document
Premium
Company Announcements
Innate Pharma Files 2024 Annual Report and Registration Document
2M ago
6K
Innate Pharma: Navigating Challenges with Promising Pipeline and Strategic Partnerships
Premium
Ratings
Innate Pharma: Navigating Challenges with Promising Pipeline and Strategic Partnerships
2M ago
IPHA
Innate Pharma Secures €15 Million Investment from Sanofi
PremiumCompany Announcements
Innate Pharma Secures €15 Million Investment from Sanofi
2M ago
6K
Innate Pharma price target lowered to $11 from $11.50 at H.C. Wainwright
PremiumThe Fly
Innate Pharma price target lowered to $11 from $11.50 at H.C. Wainwright
2M ago
IPHA
Innate Pharma announces EUR 15M capital increase from Sanofi
PremiumThe Fly
Innate Pharma announces EUR 15M capital increase from Sanofi
2M ago
SNY
IPHA
Innate Pharma Regains Rights on CD123 ANKET® and Announces Sanofi’s Strategic Investment
PremiumCompany Announcements
Innate Pharma Regains Rights on CD123 ANKET® and Announces Sanofi’s Strategic Investment
2M ago
6K
Innate Pharma regains rights to Anket, announces potential Sanofi investment
PremiumThe FlyInnate Pharma regains rights to Anket, announces potential Sanofi investment
2M ago
SNY
IPHA
Innate Pharma Proposes Governance Restructure to Align with International Standards
Premium
Company Announcements
Innate Pharma Proposes Governance Restructure to Align with International Standards
2M ago
6K
Innate Pharma Announces Annual General Meeting for May 2025
Premium
Company Announcements
Innate Pharma Announces Annual General Meeting for May 2025
2M ago
6K

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >